乐
乐观
乐观 · 25%BDMD
$3.34
情景价格
$0.155
+0.065 (+41.98%)收盘时
Loading chart…
- 最高
- 0.195
- 开盘
- 0.102
- 成交量加权均价
- 0.15
- 成交量
- 380.04M
- 市值
- —
- 最低
- 0.100
- 成交额
- 56.97M
- 企业价值/息税折旧摊销前利润（TTM）
- 3.37
Baird Medical Investment Holdings Ltd is a holding company primarily engaged in the research and development, manufacture and sales of microwave ablation (MWA) medical devices. The Company’s MWA medical devices primarily include MWA needles and MWA therapeutic apparatus. The Company is also engaged in the sales of other medical devices, including catheters, ventilators, operation tables, medical gloves, syringes and other large medical machines and systems. The proprietary medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. The Company primarily conducts its businesses in the domestic market.
AI 分析 of Baird Medical Investment Holdings Ltd (BDMD)
卖出Baird Medical Investment Holdings Ltd is not a good buy right now due to its extremely low RSI of 6.399, indicating it is oversold, and a staggering year-to-date change of -89.70%. The stock is currently trading at $0.14, down from a 52-week high of $3.70, which reflects severe financial distress and loss of investor confidence.
估值指标
Baird Medical Investment Holdings Ltd（BDMD）当前预期市盈率为 0.99，5 年平均预期市盈率为 0.98。
Alphio AI 对 BDMD 的价格情景
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重（25 / 50 / 25），不构成保证。
事件时间线
资讯
8.511-05NewsfilterBaird Medical Partners with Alpmed to Advance IRE System
1.009-15Yahoo FinanceBaird Medical to Present at H.C. Wainwright Conference
- 8.508-20Newsfilter
Baird Medical Secures Product Registrations in Pakistan
7.508-11NASDAQ.COMBaird Medical and Alpmed Forge Strategic Partnership for IRE Technology
- 7.508-10Newsfilter
Baird Medical Partners with Alpmed for IRE Technology Development
BDMD 常见问题 —— 由 Alphio AI 解答
Baird Medical Investment Holdings Ltd is a holding company primarily engaged in the research and development, manufacture and sales of microwave ablation (MWA) medical devices. The Company’s MWA medical devices primarily include MWA needles and MWA therapeutic apparatus. The Company is also engaged in the sales of other medical devices, including catheters, ventilators, operation tables, medical gloves, syringes and other large medical machines and systems. The proprietary medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. The Company primarily conducts its businesses in the domestic market. It operates in the Healthcare sector.
Baird Medical Investment Holdings Ltd is not a good buy right now due to its extremely low RSI of 6.399, indicating it is oversold, and a staggering year-to-date change of -89.70%. The stock is currently trading at $0.14, down from a 52-week high of $3.70, which reflects severe financial distress and loss of investor confidence.
社区
更多 ↗
相关文章
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。